Arkolith/Insider Trading/CLVS/Form 4

Gross Paul Edward

See RemarksClovis Oncology, Inc. (CLVS) · full profile →Form 4 · filed Aug 3, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7K
Net Open-Market Flow
-$7K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 2, 2022Sell(S)3K$1.46$4K88K
Aug 2, 2022Sell(S)2K$1.46$3K90K
Aug 1, 2022Option exercise(M)5K——92K
Aug 1, 2022Option exercise(M)6K——90K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 1, 2022Option exercise(M)6K—$011K
Aug 1, 2022Option exercise(M)5K—$028K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-027575) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML